Angela Horacek, formerly Global Vice-President of Operations and Quality for nSpire Health, has accepted the position of Vice President of Operations for Allosource. Allosource is one of the largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of live cellular bone growth substitutes.
Horacek Moves to Allosource

In her former position, Horacek was responsible for manufacturing, supply chain, logistics, facilities and quality and regulatory services for three facilities around the world. Prior to her role at nSpire Health she held positions of responsibility with several medical device organizations.
Allosource President and CEO Thomas Cycyota said,
It is with great pleasure that we welcome Angela to the Executive Leadership Team where her industry experience, strategic operational thought processes and exceptional rapport with people will be great assets to our organization.
Allosource has recently expanded into osteobiologics, which help to stimulate natural bone formation and has pioneered the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications.
Horacek holds a bachelor’s degree in chemical engineering, an MBA from the University of Louisiana and a master’s degree in Conflict Resolution from the University of Denver.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.